Risk of endometrial cancer following cessation of menopausal hormone use (Washington, United States)

Cancer Causes and Control

Volumn 7, Issue 6, 1996, Pages 575-580

  Green, Pamela K ^a,b   Weiss, Noel S ^a,b   McKnight, Barbara ^a,b   Voigt, Lynda F ^a   Beresford, Shirley A A ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Endometrial cancer; Estrogens; United States

Indexed keywords

ESTROGEN; GESTAGEN;

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; DRUG WITHDRAWAL; ENDOMETRIUM CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; UNITED STATES;

AGED; CASE-CONTROL STUDIES; ENDOMETRIAL NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; INTERVIEWS; LOGISTIC MODELS; MENOPAUSE; MIDDLE AGED; POSTMENOPAUSE; PROGESTINS; RISK; RISK ASSESSMENT; RISK FACTORS; TREATMENT REFUSAL; WASHINGTON;

EID: 0029960459     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00051699     Document Type: Article

References (22)

1. Mishell DR. Estrogen replacement therapy: an overview. Am J Obstet Gynecol 1989; 161: 1825-7.
2. Smith DC, Prentice R, Thompson DJ, et al. Association of exogenous estrogen and endometrial carcinoma. New Engl J Med 1975; 293: 1164-7.
3. Ziel HK, Finkle WD. Increased risk of endometrial carcinoma among users of conjugated estrogens. New Engl J Med 1975; 293: 1167-70.
4. Voigt LF, Weiss NS. Epidemiology of endometrial cancer. In: Surwit E, Alberts D, eds. Endometrial Cancer. Boston, MA (USA): Kluwer Academic, 1989: 1-21.
5. Voigt LF, Weiss NS, Chu J, Daling JR, McKnight B, van Belle G. Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer. Lancet 1991; 338: 274-7.
6. Henderson BE. The cancer question: an overview of recent epidemiologic and retrospective data. Am J Obstet Gynecol 1989; 6: 1859-64.
7. Herrinton LJ, Weiss NS. Postmenopausal unopposed estrogens: characteristics of use in relation to risk of endometrial carcinoma. Ann Epidemiol 1993; 3: 301-18.
8. Grady D, Rubin SM, Petitti DB, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992; 117: 1016-37.
9. Brinton LA, Hoover RN. Estrogen replacement therapy and endometrial cancer risk: unresolved issues. Obstet Gynecol 1993; 81: 265-71.
10. Waksberg J. Sampling methods for random digit dialing. J Am Stat Assoc 1978; 73: 40-6.
11. Harlow SD, Linet MS. Agreement between questionnaire data and medical records: the evidence for accuracy of recall. Am J Epidemiol 1989; 129: 233-48.
12. Grady D, Gebretsadik T, Kerlikowske K, Ernster V, Petitti D. Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol 1995; 85: 305-13.
13. Finkle WD, Greenland S, Miettinen OS, Ziel HK. Endometrial cancer risk after discontinuing use of unopposed conjugated estrogens. Cancer Causes Control 1995; 6: 99-102.
14. Hulka BS, Fowler WC, Kaufman DG, et al. Estrogen and endometrial cancer: cases and two control groups from North Carolina. Am J Obstet Gynecol 1980; 137: 92-101.
15. Paganini-Hill A, Ross RK, Henderson BE. Endometrial cancer and patterns of use of oestrogen replacement therapy: a cohort study. Br J Cancer 1989; 59: 445-7.
16. Rubin GL, Peterson HB, Lee NC, Maes EF, Wingo PA, Becker S. Estrogen replacement therapy and the risk of endometrial cancer: remaining controversies. Am J Obstet Gynecol 1990; 162: 148-54.
17. Shapiro S, Kelly JP, Rosenberg L, et al. Risk of localized and widespread endometrial cancer in relation to recent and discontinued use of conjugated estrogens. N Engl J Med 1985; 313: 969-72.
18. Weiss NS, Szekeley DR, English DR, Schweid AI. Endometrial cancer in relation to patterns of menopausal estrogen use. JAMA 1979; 242: 261-4.
19. Pettersson B, Adami HO, Persson I, Bergstrom R, Lindgren A, Johansson EDB. Climacteric symptoms and estrogen replacement therapy in women with endometrial carcinoma. Acta Obstet Gynecol Scand 1986; 65: 81-7.
20. Greenland S. Dose-response and trend analysis in epidemiology: alternatives to categorical analysis. Epidemiology 1995; 4: 356-65.
21. Persson I, Adami HO, Bergstrom R, Krusemmo UB, Hoover R. Survival in women receiving hormone replacement therapy: a record-linkage study of a large population-based cohort. J Clin Epidemiol 1990; 43: 677-85.
22. Chu J, Schwied A, Weiss N. Survival among women with endometrial cancer: a comparison of estrogen users and nonusers. Am J Obstet Gynecol 1982; 143: 569.